Experience With the Use of Baricitinib and Tocilizumab Monotherapy or Combined, in Patients With Interstitial Pneumonia Secondary to Coronavirus COVID19: A Real-World Study
Por um escritor misterioso
Descrição
Tocilizumab versus baricitinib in hospitalized patients with
Systematic review and meta-analysis of anakinra, sarilumab
Baricitinib vs tocilizumab treatment for hospitalized adult
Post-COVID-19 interstitial lung disease presenting with profound
Efficacy and safety of baricitinib for the treatment of
Efficacy of COVID-19 treatments among geriatric patients: a
Efficacy of COVID-19 treatments among geriatric patients: a
Frontiers COVID-19 and the potential of Janus family kinase (JAK
Drug repurposing approach to fight COVID-19
The signal pathways and treatment of cytokine storm in COVID-19
Post-COVID-19 interstitial lung disease presenting with profound
IJMS, Free Full-Text
de
por adulto (o preço varia de acordo com o tamanho do grupo)
